Tacke F - Search Results

1

Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases.

Streetz KL, Tacke F, Leifeld L, Wüstefeld T, Graw A, Klein C, Kamino K, Spengler U, Kreipe H, Kubicka S, Müller W, Manns MP, Trautwein C. Streetz KL, et al. Among authors: tacke f. Hepatology. 2003 Jul;38(1):218-29. doi: 10.1053/jhep.2003.50268. Hepatology. 2003. PMID: 12830005

2

Endogenous serum levels of thrombopoietic cytokines in healthy whole-blood and platelet donors: implications for plateletpheresis.

Tacke F, Schöffski P, Trautwein C, Martin MU, Stangel W, Seifried E, Manns MP, Ganser A, Petersen D. Tacke F, et al. Br J Haematol. 1999 May;105(2):511-3. doi: 10.1111/j.1365-2141.1999.01328.x. Br J Haematol. 1999. PMID: 10233430 Free article.

3

Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease.

Tacke F, Schöffski P, Trautwein C, Manns MP, Ganser A, von Depka M. Tacke F, et al. Blood Coagul Fibrinolysis. 2001 Oct;12(7):539-45. doi: 10.1097/00001721-200110000-00005. Blood Coagul Fibrinolysis. 2001. PMID: 11685041

4

Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease.

Schöffski P, Tacke F, Trautwein C, Martin MU, Caselitz M, Hecker H, Manns MP, Ganser A. Schöffski P, et al. Among authors: tacke f. Liver. 2002 Apr;22(2):114-20. doi: 10.1034/j.1600-0676.2002.01547.x. Liver. 2002. PMID: 12028404

5

Quantification of hepatic thrombopoietin mRNA transcripts in patients with chronic liver diseases shows maintained gene expression in different etiologies of liver cirrhosis.

Tacke F, Trautwein C, Zhao S, Andreeff M, Manns MP, Ganser A, Schöffski P. Tacke F, et al. Liver. 2002 Jun;22(3):205-12. doi: 10.1034/j.1600-0676.2002.01642.x. Liver. 2002. PMID: 12100570

6

Ghrelin in chronic liver disease.

Tacke F, Brabant G, Kruck E, Horn R, Schöffski P, Hecker H, Manns MP, Trautwein C. Tacke F, et al. J Hepatol. 2003 Apr;38(4):447-54. doi: 10.1016/s0168-8278(02)00438-5. J Hepatol. 2003. PMID: 12663236

7

p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.

Luedde T, Rodriguez ME, Tacke F, Xiong Y, Brenner DA, Trautwein C. Luedde T, et al. Among authors: tacke f. Hepatology. 2003 Apr;37(4):833-41. doi: 10.1053/jhep.2003.50136. Hepatology. 2003. PMID: 12668976

8

Relevance of hepatitis B core gene deletions in patients after kidney transplantation.

Bock CT, Buerke B, Tillmann HL, Tacke F, Kliem V, Manns MP, Trautwein C. Bock CT, et al. Among authors: tacke f. Gastroenterology. 2003 Jun;124(7):1809-20. doi: 10.1016/s0016-5085(03)00396-2. Gastroenterology. 2003. PMID: 12806615

9

[Treatment of hepatitis B and C virus infection].

Trautwein C, Tacke F. Trautwein C, et al. Among authors: tacke f. Dtsch Med Wochenschr. 2003 Jun 13;128 Suppl 2:S87-9. doi: 10.1055/s-2003-40144. Dtsch Med Wochenschr. 2003. PMID: 12817332 Review. German. No abstract available.

10

Plasma P-selectin levels are elevated in patients with chronic liver disease.

Tacke F, Schöffski P, Trautwein C, Luedde T, Ganser A, Manns MP, von Depka M. Tacke F, et al. Blood Coagul Fibrinolysis. 2003 Jun;14(4):319-25. doi: 10.1097/00001721-200306000-00001. Blood Coagul Fibrinolysis. 2003. PMID: 12945872

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

746 results

Search Page